QoL and mental health of of patients with BPS/IC vs. OAB & SUI

  • Research type

    Research Study

  • Full title

    Quality of life and mental health of patients with Bladder Pain Syndrome/Interstitial Cystitis compared with other urogynaecological conditions: a mixed methods study.

  • IRAS ID

    271666

  • Contact name

    Homen Chow

  • Contact email

    homen.chow@plymouth.ac.uk

  • Sponsor organisation

    University of Plymouth

  • Duration of Study in the UK

    1 years, 7 months, 1 days

  • Research summary

    This study uses a mixed method design to ascertain whether there are differences in quality of life (QoL) and mental health outcomes for people living with Bladder Pain Syndrome/Interstitial Cystitis (BPS/IC) compared to Stress Urinary Incontinence (SUI) or Overactive Bladder Syndrome (OAB). Recruitment will take place from urogynaecology clinics in a hospital setting and via online support groups for women living with the condition. BPS/IC is a chronic inflammatory pain condition related to the urinary bladder which predominately affects women. Currently, the precise causes of the disease remains unknown. Though not life-threatening, BPS/IC can severely disrupt quality of life (QoL), with profound effects on sleep and sexual dysfunction, depression, stress, and anxiety, with further adverse effects on familial relationships. SUI and OAB are two additional prevalent urogynaecological conditions affecting the urinary bladder. The central difference between BPS/IC and these urogynaecological conditions is the presence of persistent chronic pain. As such, the quantitative element of the study aims use questionnaire-based measures of QoL and mental health to ascertain whether QoL and mental health of (BPS/IC) is significantly worse than those living with SUI or OAB. The qualitative element of the study will use hour long in-depth open-ended interviews to elucidate how the condition affects the QoL and mental health of patients to provide greater detail about patient experiences of living with the condition. Currently, there is little qualitative focus on how people with BPS conceptualise their own QoL, nor how their experience of BPS affects their mental health. This information would assist clinicians in understanding how their treatment approach and the treatment pathway impact on the treatment experiences and subsequent lives of those living with BPS. It would also encourage clinicians to consider the mental health implications of living with BPS.

  • REC name

    West of Scotland REC 3

  • REC reference

    19/WS/0168

  • Date of REC Opinion

    26 Nov 2019

  • REC opinion

    Further Information Favourable Opinion